2024/10/01 by Erwan Salaün, Josep Rodés‐Cabau · 1 voice
Medicine · #Cardiac Imaging and Diagnostics #Cardiac Valve Diseases and Treatments #Cardiac tumors and thrombi
paper · pdf · doi:10.1177/30494826241296422
openalex publication_date 2024/10/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/06/15
The concept of cardiac damage staging in left-sided heart valve disease, adapted from the oncological approach, has been developed recently in order to improve the management of patients who may benefit from valve repair or replacement interventions. However, the cardiac damage is frequently not directly related to the valve disease, and cardiac and extra-cardiac non-valvular comorbidities influence the staging, unlike oncological staging where the associated damage all comes from the primary tumor. In practice, the cardiac damage classification is more an assessment of overall heart health than the direct consequences of valvular heart disease, and some cardiac damages are independent of the valve disease. Anyway, the cardiac damage staging remains a powerful predictor of outcome, especially after valve intervention. This viewpoint explores the concept of cardiac damage staging and the impact of the valve intervention on this classification.